Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Flu is rising rapidly, driven by a new variant. Here's what to know - 2New UPS distribution center in Taiwan doubles capacity, productivity
- 3Top 15 Web-based Entertainment Stages for Individual Marking
- 4Upgrading the Healthy benefit of Your Local Vegetables
- 5When does Spotify Wrapped come out? The music streamer says 'soon.'
- 'Stranger Things' Season 5: What's going on with Will Byers? That shocking Volume 1 plot twist, explained.
- Foot fossil discovery could reshape human evolutionary history
- New research reveals urban raccoons across the US show early signs of domestication
- Tanzania president remorseful over internet shutdown on election day
- ADHD drugs work, but not the way experts thought
- 'Zootopia 2' movie reviews: A heartwarming, hysterical and earnest 'ode to community'
- Investigate the Excellence of Professional flowerbeds: A Virtual Local escort
- Satellite space quiz: What's orbiting Earth?
- Independence from the rat race for Recent college grads: Systems and Tips
